[99mTc]-HM-PAO SPECT in Parkinson's Disease
暂无分享,去创建一个
M. Dam | L. Battistin | G. Pizzolato | P. Zanco | G. Ferlin | G Pizzolato | G Ferlin | M Dam | L Battistin | P Zanco | N Borsato | B Saitta | C Da Col | N Perlotto | N. Borsato | B. Saitta | N. Perlotto | C. Da Col | C. D. Col
[1] F. Boiler. Mental status of patients with parkinson disease , 1980 .
[2] Y. Agid,et al. CCK-8-immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients , 1982, Brain Research.
[3] K. Jellinger,et al. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.
[4] P. Jarritt,et al. A 99Tcm-labelled radiotracer for the investigation of cerebral vascular disease , 1985, Nuclear medicine communications.
[5] O. Hornykiewicz,et al. Distribution of high affinity sodium-independent [3H]gamma-aminobutyric acid ([3H]GABA) binding in the human brain: Alterations in Parkinson's disease , 1977, Brain Research.
[6] G. Deutsch,et al. Cerebral blood flow in severity‐matched Alzheirner and multi‐infarct patients , 1987, Neurology.
[7] E. London,et al. Effects of oxotremorine on local glucose utilization in the rat cerebral cortex , 1982, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[8] J. Haxby,et al. Positron emission tomography in Alzheimer's disease , 1986, Neurology.
[9] S. Rapoport,et al. Stimulatory Effect of the D2 Antagonist Sulpiride on Glucose Utilization in Dopaminergic Regions of Rat Brain , 1987, Journal of neurochemistry.
[10] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[11] T Jones,et al. Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography. , 1986, Journal of neurology, neurosurgery, and psychiatry.
[12] Marcus E. Raichle,et al. Regional blood flow in herniparkinsonism , 1985, Neurology.
[13] M. Albert,et al. Muscarinic acetylcholine receptors in Alzheimer's disease. In vivo imaging with iodine 123-labeled 3-quinuclidinyl-4-iodobenzilate and emission tomography. , 1985, JAMA.
[14] P. Mcgeer,et al. Aging and extrapyramidal function. , 1977, Archives of neurology.
[15] T Jones,et al. Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease , 1985, Neurology.
[16] A. Hakim,et al. Dementia in Parkinson disease , 1979, Neurology.
[17] O. Hornykiewicz. Dopamine (3-hydroxytyramine) and brain function. , 1966, Pharmacological reviews.
[18] M. Kupersmith,et al. Dementia in Parkinson disease , 1979, Annals of neurology.
[19] W. Jagust,et al. The diagnosis of dementia with single photon emission computed tomography. , 1987, Archives of neurology.
[20] U. Rinne,et al. Brain catecholamines and their metabolites in Parkinsonian patients. Treatment with levodopa alone or combined with a decarboxylase inhibitor. , 1973, Archives of neurology.
[21] L. Henriksen,et al. Regional cerebral blood flow in hemiparkinsonian patients. Emission computerized tomography of inhaled 133Xenon before and after levodopa , 1985, Acta neurologica Scandinavica.
[22] E. London,et al. Glucose utilization in the Papez circuit: Effects of oxotremorine and scopolamine , 1984, Brain Research.
[23] P F Sharp,et al. Technetium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[24] M. Hoehn,et al. Parkinsonism , 1967, Neurology.
[25] A. Hirano,et al. AN ATLAS OF THE HUMAN BRAIN FOR COMPUTERIZED TOMOGRAPHY. , 1978 .
[26] Y. Agid,et al. Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia , 1982, Brain Research.
[27] R Harrop,et al. Cerebral Glucose Metabolism in Parkinson’s Disease , 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[28] N. Foster,et al. Alzheimer's disease , 1983, Neurology.
[29] Y Agid,et al. Is the mesocortical dopaminergic system involved in Parkinson disease? , 1980, Neurology.
[30] Stanley I. Rapoport,et al. Arecoline-induced elevations of regional cerebral metabolism in the conscious rat , 1985, Brain Research.
[31] J. Coyle,et al. Jo U Rnal of Cerebral Blood Flow and Metabolism Decreased Cortical Glucose Utilization after Ibotenate Lesion of the Rat Ventromedial Globus Pallidus , 2022 .
[32] R A Holmes,et al. Technetium-99 m d , l-HM-PAO : A New Rathopharmaceutical for SPECT Imaging of Regional CerebralBlood Perfusion , 2006 .
[33] D. Nowotnik,et al. Technetium-99m-d, 1-HM-PAO: a new radiopharmaceutical for imaging regional brain perfusion using SPECT--a comparison with iodine-123 HIPDM. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[34] M E Raichle,et al. Regional blood flow in hemiparkinsonism. , 1985, Neurology.
[35] T. Jones,et al. Regional impairment of cerebral oxidative metabolism in Parkinson's disease. , 1979, Journal of neurology, neurosurgery, and psychiatry.
[36] S. Rapoport,et al. Time-course and regional distribution of the metabolic effects of bromocriptine in the rat brain , 1985, Brain Research.
[37] T T Soncrant,et al. Haloperidol and Cerebral Metabolism in the Conscious Rat: Relation to Pharmacokinetics , 1984, Journal of neurochemistry.
[38] P. Seeman,et al. Dopamine D2 receptor density in parkinsonian brain is constant for duration of disease, age, and duration of L-dopa therapy. , 1987, Advances in neurology.
[39] U. Roessmann,et al. Parkinson disease, dementia, and alzheimer disease: Clinicopathological correlations , 1980, Annals of neurology.
[40] D L Price,et al. Basal forebrain neurons in the dementia of Parkinson disease , 1983, Annals of neurology.
[41] D E Kuhl,et al. Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method , 1984, Annals of neurology.
[42] E. Melamed,et al. Cerebral blood flow and cognitive impairment in Parkinson's disease , 1985, Neurology.
[43] Olaf B. Paulson,et al. The Retention of [99mTc]-d,l-HM-PAO in the Human Brain after Intracarotid Bolus Injection: A Kinetic Analysis , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.